Valneva logo

Valneva

VALN | NASDAQ
Chart Builder DCF Calculator
$5.73
+$0.07 (+1.24%)
At close: Nov 16, 2026, 3:59 PM ET
$5.67
-$0.06 (-1.05%)
After-hours: Nov 16, 2026, 5:31 PM ET
+1.24%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
22.5
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #974/1021 (Top 95%)

Key Statistics

Market Data

Market Cap $545.08M
1D Range
5.59 5.74
52W Range
4.78 11.99

Valuation (TTM)

PE -2.70
PB 5.89
EV/EBITDA -6.07

Valuation (NTM)

Forward PE 8.79
Forward PEG 0.32
Price Target $11.00
Loading financial charts...

Profile

Valneva SE operates as a specialized biopharmaceutical company, concentrating its efforts on developing and bringing to market preventative vaccines for infectious diseases where current medical optio...

Sector Healthcare
Industry Biotechnology
Employees 674
IPO Date May 5, 2021
Website valneva.com
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Nov 24, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Sell
Price Target
$11.00
Upside
+91.97%
Buy (0)
Hold (0)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.